Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022-Reference-Cited by-同舟云学术

Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022

Published:2023-05-11 Issue:19 Volume:28 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Linkevicius Marius¹,Bonnin Rémy A²,Alm Erik¹,Svartström Olov¹,Apfalter Petra³,Hartl Rainer³,Hasman Henrik⁴,Roer Louise⁴,Räisänen Kati⁵,Dortet Laurent²,Pfennigwerth Niels⁶,Hans Jörg B⁶,Tóth Ákos⁷,Buzgó Lilla⁷,Cormican Martin⁸,Delappe Niall⁸,Monaco Monica⁹,Giufrè Maria⁹,Hendrickx Antoni PA¹⁰,Samuelsen Ørjan¹¹¹²,Pöntinen Anna K¹³¹²,Caniça Manuela¹⁴,Manageiro Vera¹⁴,Oteo-Iglesias Jesús¹⁵,Pérez-Vázquez María¹⁵,Westmo Karin¹⁶,Mäkitalo Barbro¹⁶,Palm Daniel¹,Monnet Dominique L¹,Kohlenberg Anke¹

Affiliation:

1. European Centre for Disease Prevention and Control, Stockholm, Sweden

2. French National Reference Center for Antimicrobial Resistance, INSERM UMR 1184, Paris-Saclay University, Bicêtre Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France

3. Austrian National Reference Centre for Antimicrobial Resistance, Ordensklinikum Linz Elisabethinen, Linz, Austria

4. Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark

5. Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland

6. National Reference Centre for multidrug-resistant Gram-negative bacteria, Ruhr University Bochum, Bochum, Germany

7. National Public Health Centre, Budapest, Hungary

8. University of Galway, Galway, Ireland

9. Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy

10. Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment, Bilthoven, the Netherlands

11. Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway

12. Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, University Hospital of North Norway, Tromsø, Norway

13. Department of Biostatistics, Faculty of Medicine, University of Oslo, Oslo, Norway

14. National Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal

15. Laboratorio de Referencia e Investigación en Resistencia a Antibióticos del Centro Nacional de Microbiología and CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain

16. Public Health Agency of Sweden, Stockholm, Sweden

Abstract

Whole genome sequencing data of 874 Escherichia coli isolates carrying bla NDM-5 from 13 European Union/European Economic Area countries between 2012 and June 2022 showed the predominance of sequence types ST167, ST405, ST410, ST361 and ST648, and an increasing frequency of detection. Nearly a third (30.6%) of these isolates were associated with infections and more than half (58.2%) were predicted to be multidrug-resistant. Further spread of E. coli carrying bla NDM-5 would leave limited treatment options for serious E. coli infections.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference20 articles.

1. European Centre for Disease Prevention and Control (ECDC). ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level. Version 2.0. Stockholm: ECDC; 2018. Available from: https://ecdc.europa.eu/en/publications-data/ecdc-study-protocol-genomic-based-surveillance-carbapenem-resistant-andor

2. Global extraintestinal pathogenic Escherichia coli (ExPEC) lineages.;Manges;Clin Microbiol Rev,2019

3. The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity.;Zhou;Genome Res,2020

4. Multilocus sequence typing of total-genome-sequenced bacteria.;Larsen;J Clin Microbiol,2012

5. Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015-2017.;Peirano;Emerg Infect Dis,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissemination of blaNDM-5 Driven by Horizontal Transfer of IncFIA Plasmid Between Escherichia coli and Klebsiella pneumoniae Co-Isolated from a Patient’s Ascitic Fluid;Infection and Drug Resistance;2024-09

2. Molecular characterization of carbapenem and ceftazidime-avibactam-resistant Enterobacterales and horizontal spread of blaNDM-5 gene at a Lebanese medical center;Frontiers in Cellular and Infection Microbiology;2024-06-19

3. Characterizing carbapenemase-producing Escherichia coli isolates from Spain: high genetic heterogeneity and wide geographical spread;Frontiers in Cellular and Infection Microbiology;2024-05-16

4. A new in vivo model of intestinal colonization using Zophobas morio larvae: testing hyperepidemic ESBL- and carbapenemase-producing Escherichia coli clones;Frontiers in Microbiology;2024-04-10

5. Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–21;International Journal of Antimicrobial Agents;2024-04